AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of THB 12.84 trillion. The enterprise value is 14.91 trillion.
| Market Cap | 12.84T |
| Enterprise Value | 14.91T |
Important Dates
The next estimated earnings date is Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | Oct 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 73.84% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 106.21 and the forward PE ratio is 19.23.
| PE Ratio | 106.21 |
| Forward PE | 19.23 |
| PS Ratio | 6.78 |
| PB Ratio | -2,865.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 21.68 |
| P/OCF Ratio | 20.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.25, with an EV/FCF ratio of 25.18.
| EV / Earnings | 123.34 |
| EV / Sales | 7.92 |
| EV / EBITDA | 16.25 |
| EV / EBIT | 23.32 |
| EV / FCF | 25.18 |
Financial Position
The company has a current ratio of 0.74
| Current Ratio | 0.74 |
| Quick Ratio | 0.48 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.48 |
| Debt / FCF | 3.87 |
| Interest Coverage | 6.92 |
Financial Efficiency
Return on equity (ROE) is 112.85% and return on invested capital (ROIC) is 16.70%.
| Return on Equity (ROE) | 112.85% |
| Return on Assets (ROA) | 8.87% |
| Return on Invested Capital (ROIC) | 16.70% |
| Return on Capital Employed (ROCE) | 20.33% |
| Revenue Per Employee | 34.44M |
| Profits Per Employee | 2.20M |
| Employee Count | 55,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.65 |
Taxes
| Income Tax | -24.07B |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.04 |
| Average Volume (20 Days) | 65,021 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.35 |
Income Statement
In the last 12 months, AbbVie had revenue of THB 1.89 trillion and earned 120.91 billion in profits. Earnings per share was 68.21.
| Revenue | 1.89T |
| Gross Profit | 1.35T |
| Operating Income | 643.18B |
| Pretax Income | 98.41B |
| Net Income | 120.91B |
| EBITDA | 911.77B |
| EBIT | 643.18B |
| Earnings Per Share (EPS) | 68.21 |
Balance Sheet
The company has 210.03 billion in cash and 2.29 trillion in debt, giving a net cash position of -2,082.39 billion.
| Cash & Cash Equivalents | 210.03B |
| Total Debt | 2.29T |
| Net Cash | -2,082.39B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -4.48B |
| Book Value Per Share | -3.36 |
| Working Capital | -341.21B |
Cash Flow
In the last 12 months, operating cash flow was 626.26 billion and capital expenditures -33.91 billion, giving a free cash flow of 592.36 billion.
| Operating Cash Flow | 626.26B |
| Capital Expenditures | -33.91B |
| Free Cash Flow | 592.36B |
| FCF Per Share | n/a |
Margins
Gross margin is 71.25%, with operating and profit margins of 33.95% and 6.45%.
| Gross Margin | 71.25% |
| Operating Margin | 33.95% |
| Pretax Margin | 5.19% |
| Profit Margin | 6.45% |
| EBITDA Margin | 48.13% |
| EBIT Margin | 33.95% |
| FCF Margin | 31.27% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 0.59%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 0.59% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 301.30% |
| Buyback Yield | -0.03% |
| Shareholder Yield | 0.56% |
| Earnings Yield | 0.94% |
| FCF Yield | 4.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AbbVie has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.14 |
| Piotroski F-Score | 6 |